Commonwealth Scientific and Industrial Research Organisation

Limagrain Cereales Ingredients S.a.

Other

The University of New South Wales

Goodman Fielder Pte. Ltd

Burns Philp & Company Limited

Arnott's Biscuits Limited

Burns Philp Research & Development Pty Limited

Gist-brocades Australia Pty Limited

Goodman Fielder Ingredients Limited

Monash University

Limagrain Céréales Ingrédients

David Lloyd Topping

Matthew Kennedy Morell

Anthony Richard Bird

Zhongyi Li

Ahmed Regina

Sadequr Rahman

Gulay Saygat Mann

Ian L Brown

Patricia Lynne Conway

Xin Wang

Ian Leslie Batey

Kenneth John McNaught

Robert N Ganly

Anthony John Evans

Ian R Record

Geoffrey Annison

Richard J Illman

Julie Clarke

Trevor Lockett

A method and composition for improving one or more indicators of bowel health or metabolic health in a mammalian animal. This comprises the delivering to the gastrointestinal tract of the animal an effective amount of an altered wheat starch in the form of or derived from the grain of a wheat plant. The proportion of amylose in the starch of the grain is at least 30% and/or the grain comprises a reduced level of SBEIIa enzyme activity and/or protein relative to wild-type grain.

Method and means for improving bowel health

Barley with reduced SSII activity has a starch structure with reduced amylopectin content and a consequent high relative amylose content. Additionally the grain can have a relatively high &#x3b2; glucan content. The structure of the starch may also be altered in a number of ways which can be characterized by having a low gelatinzation temperature but with reduced swelling. The viscosity of gelatinized starch of the starch is also reduced. There is a chain length distribution of the amylopectin content and a low crystallinity of the starch. The starch is also characterized by having high levels of lipid associated starch exhibiting very high levels of V form starch crystallinity. The dietary fiber content of the starch is high. This has desirable dietary and food processing characteristics.

Barely with reduced SSII activity and starch and starch containing products with a reduced amylopectin content

A method and composition for improving one or more indicators of bowel health or metabolic health in a mammalian animal. This comprises the delivering to the gastrointestinal tract of the animal an effective amount of an altered wheat starch in the form of or derived from the grain of a wheat plant. The proportion of amylose in the starch of the grain is at least 30%.

Barley with reduced SSII activity has a starch structure with reduced amylopectin content and a consequent high relative amylose content. Additionally the grain can have a relatively high &#x3b2; glucan content. The structure of the starch may also be altered in a number of ways which can be characterized by having a low gelatinsation temperature but with reduced swelling. The viscosity of gelatinised starch of the starch is also reduced. There is a chain length distribution of the amylopectin content and a low crystallinity of the starch. The starch is also characterized by having high levels of lipid associated starch exhibiting very high levels of V form starch crystallinity. The dietary fiber content of the starch is high. This has desirable dietary and food processing characteristics.

Barley with reduced SSII activity and starch containing products with a reduced amylopectin content

The present invention relates to a nasogastric formulation comprising an amino acid source, a carbohydrate source, a lipid source, and a fatty acid delivery agent wherein the fatty acid has a bond hydrolysable in the colon to deliver free fatty acids such as short chain fatty acid acetate without having an adverse affect on the capacity to pass through a tube for tube feeding.

Nasogastric enteral formulations

Probiotic composition comprising one or more probiotic microorganisms, a carrier which will function to transport the one or more probiotic microorganisms to the large bowel or other regions of the gastrointestinal tract of an animal, the carrier comprising a modified or unmodified resistant starch or mixtures thereof, which carrier acts as a growth or maintenance medium for microorganisms in the large bowel or other regions of the gastrointestinal tract, and an oligosaccharide. Method of increasing the number of probiotic or resident microorganisms in the gastrointestinal tract of an animal comprising providing to the animal the probiotic composition.

Enhancement of microbial colonisation of the gastrointestinal tract

Probiotic compositions

Fatty acid delivery system comprising a hydrolyzable bond

Growing community of inventors

Victor Harbor, Australia

David Lloyd Topping